Abstract: The present invention relates, in part, to methods for selecting subjects for and treating subjects with a type of immunotherapy based on certain biomarkers from the subjects.

Abstract: The reinforced shoe heel includes an angled platform having a surface area for supporting a heel section of a shoe, a core including a plate and at least one reinforcement rod extending therefrom, the plate having a size and shape for select imbedded seated reception on a top surface of the angled platform, and a support coupled with and extending below the angled platform, the support being positioned in relation relative to the core to selectively receive the at least one reinforcement rod projecting from the plate. The reinforcement rod cooperates with the top-mounted plate to increase the relative structural rigidity of the reinforced shoe heel to generally relatively resist torsion, compressive, and shear stresses during use when attached to the shoe.

Abstract: The machine is configured to perform an automated rapid plasma reagent (RPR) agglutination test or other agglutination test. The machine includes a sample rack with multiple sample locations thereon and a reagent rack for storing of reagent. A shaker assembly supports at least one microtiter plate or other well supporting structure thereon with a plurality of wells in the plate. An automated pipette accesses samples and reagent and deposits them within wells of the microtiter plate. The shaker assembly shakes multiple samples within the wells of the microtiter plate. Finally, a camera photographs the wells of the plate, preferably from above with a light source below and the plate at least partially transparent. The image is then analyzed in an automated fashion to determine whether a ring of contrast material has remained smooth indicative of a non-reactive sample or has agglutinated/clumped together indicative of a reactive sample.

Abstract: The reinforced shoe heel includes an angled platform having a surface area for supporting a heel section of a shoe, a core including a plate and at least one reinforcement rod extending therefrom, the plate having a size and shape for select imbedded seated reception on a top surface of the angled platform, and a support coupled with and extending below the angled platform, the support being positioned in relation relative to the core to selectively receive the at least one reinforcement rod projecting from the plate. The reinforcement rod cooperates with the top-mounted plate to increase the relative structural rigidity of the reinforced shoe heel to generally relatively resist torsion, compressive, and shear stresses during use when attached to the shoe.

Abstract: The machine is configured to perform an automated rapid plasma reagent (RPR) agglutination test or other agglutination test. The machine includes a sample rack with multiple sample locations thereon and a reagent rack for storing of reagent. A shaker assembly supports at least one microtiter plate or other well supporting structure thereon with a plurality of wells in the plate. An automated pipette accesses samples and reagent and deposits them within wells of the microtiter plate. The shaker assembly shakes multiple samples within the wells of the microtiter plate. Finally, a camera photographs the wells of the plate, preferably from above with a light source below and the plate at least partially transparent. The image is then analyzed in an automated fashion to determine whether a ring of contrast material has remained smooth indicative of a non-reactive sample or has agglutinated/clumped together indicative of a reactive sample.

Abstract: The machine is configured to perform an automated rapid plasma reagent (RPR) agglutination test or other agglutination test. The machine includes a sample rack with multiple sample locations thereon and a reagent rack for storing of reagent. A shaker assembly supports at least one microtiter plate or other well supporting structure thereon with a plurality of wells in the plate. An automated syringe or other aspirator and dispenser accesses samples and reagent and deposits them within wells of the microtiter plate. The shaker assembly shakes multiple samples within the wells of the microtiter plate according to the RPR or other agglutination test. Finally, a camera photographs the wells of the plate, preferably from above with a light source below and the plate at least partially transparent, to evaluate whether the specimen is reactive or non-reactive. Test results and photographic evidence of the test results are preferably archived within a database.

Abstract: The automated reader operates within an enclosure also containing a sample rack and reagent rack, as well as a microtiter plate with multiple wells therein. The machine automatically loads sample and reagent into a well of the microtiter plate according to a testing protocol. The specimen can then be moved along with the microtiter plate into a slot of the reader and aligned with either a light source and detector for an optical density read or aligned with a photon counter for a chemiluminescence read. The reader includes a shroud assembly which can be raised and lowered by a lift assembly to occlude a read point from photons other than those emanating from the sample.

Abstract: Providing previews of seek locations in digital media is disclosed. While playback of the media content is progressing as normal a snapshot such as a thumbnail is displayed to show the user a representation of the media content that is associated with a seek location. The functionality of a transport key may be temporarily modified. The temporary modification allows the user to seek to a desired location very accurately and may result in fewer input keys being selected. Moreover, because the modification is temporary a great deal of flexibility is provided.

Abstract: The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen type-IV with substantially greater affinity than to the native triple helical form of collagen type-IV. Methods utilizing such antagonists for therapeutic treatment of tumor growth, tumor metastasis or of restenosis also are described, as are methods to use such antagonists as diagnostic markers of angiogenesis in normal or diseased tissues both in vivo and ex vivo. The invention further describes methods for treating tumors using said antagonists in combination with radiation therapy and therapies comprising the antagonists and radiation treatment.

Abstract: Techniques are disclosed herein for controlling playback of digital media. In one aspect, while playback of the media content is progressing as normal a snapshot such as a thumbnail is displayed to show the user a representation of the media content that is associated with a seek location. In another aspect, the functionality of a transport key is temporarily modified. The temporary modification allows the user to seek to a desired location very accurately and may result in fewer input keys being selected. Moreover, because the modification is temporary a great deal of flexibility is provided.

Abstract: The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen type-IV with substantially greater affinity than to the native triple helical form of collagen type-IV. Methods utilizing such antagonists for therapeutic treatment of tumor growth, tumor metastasis or of restenosis also are described, as are methods to use such antagonists as diagnostic markers of angiogenesis in normal or diseased tissues both in vivo and ex vivo. The invention further describes methods for treating tumors using said antagonists in combination with radiation therapy and therapies comprising the antagonists and radiation treatment.

Abstract: The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen type-IV with substantially greater affinity than to the native triple helical form of collagen type-IV. Methods utilizing such antagonists for therapeutic treatment of tumor growth, tumor metastasis or of restenosis also are described, as are methods to use such antagonists as diagnostic markers of angiogenesis in normal or diseased tissues both in vivo and ex vivo. The invention further describes methods for treating tumors using said antagonists in combination with radiation therapy and therapies comprising the antagonists and radiation treatment.

Abstract: The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen type-IV with substantially greater affinity than to the native triple helical form of collagen type-IV. Methods utilizing such antagonists for therapeutic treatment of tumor growth, tumor metastasis or of restenosis also are described, as are methods to use such antagonists as diagnostic markers of angiogenesis in normal or diseased tissues both in vivo and ex vivo. The invention further describes methods for treating tumors using said antagonists in combination with radiation therapy and therapies comprising the the antagonists and radiation treatment.